Jupiter Neurosciences, Inc. announced on June 30, 2025, the unveiling of Nugevia™ PWR, a daily mitochondrial health supplement. This product is scientifically formulated to support cellular energy, endurance, and recovery.
PWR combines JOTROL™ with NovaSOL® solubilized CoQ10, aiming to optimize energy production and protect against oxidative stress. Commercial availability for PWR is expected in Fall 2025, targeting the longevity and wellness markets.
This product reinforces Jupiter's strategy of monetizing its proprietary science across both pharmaceutical and consumer verticals. Nugevia™ PWR is expected to serve as a high-margin revenue driver supporting therapeutic development.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.